Ameritas Investment Partners’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1K | Hold |
1,009
| – | – | ﹤0.01% | 2791 |
|
|
2025
Q1 | $11.8K | Hold |
1,009
| – | – | ﹤0.01% | 2768 |
|
|
2024
Q4 | $23.1K | Hold |
1,009
| – | – | ﹤0.01% | 2566 |
|
|
2024
Q3 | $42.3K | Hold |
1,009
| – | – | ﹤0.01% | 2290 |
|
|
2024
Q2 | $36.7K | Buy |
+1,009
| New | +$36.7K | ﹤0.01% | 2308 |
|
|
2022
Q2 | – | Sell |
-131
| Closed | -$5K | – | 3178 |
|
|
2022
Q1 | $5K | Hold |
131
| – | – | ﹤0.01% | 2972 |
|
|
2021
Q4 | $13K | Hold |
131
| – | – | ﹤0.01% | 2821 |
|
|
2021
Q3 | $19K | Hold |
131
| – | – | ﹤0.01% | 2733 |
|
|
2021
Q2 | $24K | Hold |
131
| – | – | ﹤0.01% | 2650 |
|
|
2021
Q1 | $32K | Hold |
131
| – | – | ﹤0.01% | 2339 |
|
|
2020
Q4 | $37K | Hold |
131
| – | – | ﹤0.01% | 2158 |
|
|
2020
Q3 | $31K | Hold |
131
| – | – | ﹤0.01% | 2144 |
|
|
2020
Q2 | $44K | Buy |
+131
| New | +$44K | ﹤0.01% | 1912 |
|